Charles river
Charles River Laboratories is a global contract research organization that provides preclinical and clinical laboratory services, research models, and related support to pharmaceutical, biotechnology, and medical device companies, as well as academic and government institutions. The company helps clients discover, develop, and safely manufacture new drugs and therapies by offering in vivo and in vitro testing, safety assessment, biologics testing, and manufacturing support services. It generates revenue through fee-for-service research, laboratory services, and the sale of research models and related products.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1947
- Headquarters
- Wilmington Manor, United States of America
Charles river customers on Arbolus
Customers who reviewed Charles river
Seniority of Charles river customers
The largest group of people who reviewed Charles river holds C-Suite roles (46%), followed by Director (38%) and Manager (15%).
- C-Suite 46%
- Director 38%
- Manager 15%
Customers sample
Employer names and spend open in the full report, along with the other 35 customers.
What 38 Arbolus experts think of Charles river
Overall sentiment: Positive
NPS scores are predominantly positive with a concentration in the 8–10 range, but a minority of detractors brought the mean down. Renewal intent is mixed—several large accounts are unsure or plan not to renew, reflecting concerns around evolving regulatory alternatives and budget reevaluations. Most users are in the mature implementation stage (>12 months), indicating deep product adoption and high workflow integration. Experts repeatedly cite Charles River’s strong scientific staff, regulatory compliance, and lab infrastructure as key assets, but also acknowledge ongoing market shifts towards alternatives like NAMs.
Everything 38 customers told us about Charles river.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
28 Net Promoter Score, from 38 scored reviews- Promoters 17
- Passives 15
- Detractors 6
Praised
- Regulatory Collaboration
- Adoption of New Approach Methodologies
- Workflow Digitalization
- Workflow Acceleration
Criticised
- Manual Labor Dependence
- Technology Displacement Threat
- Regulatory Shift Risk
- Regulatory Disruption Risk
What Charles river customers say
Workflow Acceleration
“With their integrated pharmacology and toxicology services, I accelerate study execution and advance therapeutic candidates more efficiently.”
High Data Quality
“The quality of preclinical safety data Charles River generates supports key development decisions and regulatory filings for our pipeline.”
Comprehensive Preclinical Capabilities
“I find Charles River's broad expertise in GLP and non-GLP in vivo studies, supported by advanced labs and extensive animal models, critical for R&D progress.”
Renewal intent
Plan to renew 41%Plan to renew, by seniority
- 41% 17 answers
- 29% 7 answers
- 60% 5 answers
- 8.6/10 Average score from customers who will renew
- 8/10 Average score from undecided customers
- 6.3/10 Average score from customers not renewing
Top alternatives
Most weighed by Charles river customersReport
For people who use Charles river
Do you use Charles river at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 38 customers of Charles river have already contributed
Takes a few minutes. Your identity stays anonymous.